UK medical device industry matures nicely
This article was originally published in Clinica
The UK's medical device industry is likely to see many new faces over the next five years given that one-fifth of the 1,921 company directors are over 60. These are the findings of a survey by Plimsoll Publishing. The report indicates that of the 264 companies run by the over 60s, almost 42% are being run successfully, compared to an industry average of just 40%.
You may also be interested in...
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.